Literature DB >> 15943066

Development of a hamster model of Chlamydophila pneumoniae infection.

A Marangoni1, V Sambri, M Donati, K Di Leo, R Cevenini.   

Abstract

The aim of this study was to develop a new experimental model of Chlamydophila pneumoniae infection in the hamster. Intraperitoneal injection of C. pneumoniae purified elementary bodies (EBs) in the hamsters caused a systemic infection, since it was possible to isolate viable chlamydiae from several organs up to 14 days after infection. In particular, spleen infection was detectable up to 7 days post infection in 100% of animals. In contrast, cultures of the organs obtained from intranasally infected animals were far less frequently positive. Systemic infection probably occurred via macrophages, as demonstrated by the presence of intracellular chlamydial inclusions in peritoneal macrophages of peritoneally inoculated animals four days after infection. Furthermore, by infecting LLC-MK2 cells with supernatant preparations obtained from these macrophages, it was possible to observe the development of chlamydial intra-cytoplasmic inclusions after 96 h. Immunization of 18 hamsters with heat-inactivated purified EBs completely protected 16 animals and substantially reduced infection levels in the remaining two. Sera obtained from immunized hamsters prior to challenge reacted mainly against two C. pneumoniae proteins of about 60 kDa, when tested by immunoblot.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15943066     DOI: 10.1007/s11259-005-0837-z

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  24 in total

1.  Comparative in vitro activity of five cathelicidin-derived synthetic peptides against Leptospira, Borrelia and Treponema pallidum.

Authors:  Vittorio Sambri; Antonella Marangoni; Lorenzo Giacani; Renato Gennaro; Rossella Murgia; Roberto Cevenini; Marina Cinco
Journal:  J Antimicrob Chemother       Date:  2002-12       Impact factor: 5.790

2.  Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse.

Authors:  T C Moazed; C C Kuo; J T Grayston; L A Campbell
Journal:  J Infect Dis       Date:  1998-05       Impact factor: 5.226

3.  Immunogenic and protective ability of the two developmental forms of Chlamydiae in a mouse model of infertility.

Authors:  S Pal; J Rangel; E M Peterson; L M de la Maza
Journal:  Vaccine       Date:  1999-11-12       Impact factor: 3.641

4.  Persistent cardiac and urinary tract infections with Borrelia burgdorferi in experimentally infected Syrian hamsters.

Authors:  J L Goodman; P Jurkovich; C Kodner; R C Johnson
Journal:  J Clin Microbiol       Date:  1991-05       Impact factor: 5.948

5.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Humoral immune response to plasmid protein pgp3 in patients with Chlamydia trachomatis infection.

Authors:  M Comanducci; R Manetti; L Bini; A Santucci; V Pallini; R Cevenini; J M Sueur; J Orfila; G Ratti
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

8.  Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis.

Authors:  J T Grayston; M B Aldous; A Easton; S P Wang; C C Kuo; L A Campbell; J Altman
Journal:  J Infect Dis       Date:  1993-11       Impact factor: 5.226

9.  A mouse model of Chlamydia pneumoniae strain TWAR pneumonitis.

Authors:  Z P Yang; C C Kuo; J T Grayston
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

10.  Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study.

Authors:  P Saikku; M Leinonen; L Tenkanen; E Linnanmäki; M R Ekman; V Manninen; M Mänttäri; M H Frick; J K Huttunen
Journal:  Ann Intern Med       Date:  1992-02-15       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.